Home

Brett R. Hagen, Chief Accounting Officer: Kalaris Therapeutics KLRS Sell · Filed 23/08/21

Trade details

Type
Insider sale
Amount
$4,132.5
Shares · price
1,653 sh · $2.50 a share
Held after
127,175 sh
Trade date
23/08/17
Filed
23/08/21
Days to filing
4 days

Sold 1.3% of holdings

Share of holding sold
1.3%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 23/07/18~23/09/16

Brett R. Hagen's recent trades

  • Brett R. Hagen

    SellKalaris Therapeutics

    $12.9K

    Filed 03/23

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $12.9K

    Filed 03/20

  • Brett R. Hagen

    SellKalaris Therapeutics

    $8,136

    Filed 25/03/27

  • Brett R. Hagen

    SellKalaris Therapeutics

    $968

    Filed 25/02/24

  • Brett R. Hagen

    Planned saleKalaris Therapeutics

    $967

    Filed 25/02/24